Citadel Advisors »

Acurx Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Acurx Pharmaceuticals (ACXP) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Acurx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acurx Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acurx Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $201k 52k 3.83
2023-09-30 $27k 19k 1.43

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Acurx Pharmaceuticals

Vanguard Group
Prospect Financial Services
Advisor Group Holdings
Citadel Advisors
TD Waterhouse Canada
Nbc Securities
Tocqueville Asset Management
Simplex Trading
Sigma Planning
Cambridge Investment Research Advisors
Semmax Financial Advisors
Cornerstone Planning Group
Cutler
Advisory Services Network
Jpmorgan Chase & Co

View all funds holding Acurx Pharmaceuticals